Stock USNA USANA HEALTH SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus USANA Health Sciences, Inc.

Equities

USNA

US90328M1071

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-29 pm EDT 		5-day change 1st Jan Change
42.98 USD -1.13% Intraday chart for USANA Health Sciences, Inc. -2.83% -19.81%
Mar. 11 Usana Health Sciences Insider Sold Shares Worth $539,539, According to a Recent SEC Filing MT
Mar. 11 Usana Health Sciences Insider Sold Shares Worth $257,022, According to a Recent SEC Filing MT

Evolution of the average Target Price on USANA Health Sciences, Inc.

Price target over the last 5 years

History of analyst recommendation changes

de34eb2c83fb.a3YzEcTTaJxQ-FU2ETE70s-pgAmTqGd19G6oMIrt3-I.AUBjer6CXM4eqBNXaVVd_62E4WH-mlQCxxnAZLzajKQZLHxp9bwC7R2THA~0ce474ea51c24d1ac30fb59e59278d97

Analyst Recommendations on USANA Health Sciences, Inc.

DA Davidson Cuts USANA Health Sciences' Price Target to $53 From $62, Keeps Neutral Rating MT
DA Davidson Adjusts USANA Health Sciences' Price Target to $56 From $52.50, Keeps Neutral Rating MT
DA Davidson Adjusts USANA Health Sciences' Price Target to $52.50 From $49, Keeps Neutral Rating MT
DA Davidson Adjusts USANA Health Sciences' Price Target to $49 From $57, Keeps Neutral Rating MT
DA Davidson Lowers Price Target for USANA Health Sciences to $58 From $76, Maintains Neutral Rating MT
Jefferies & Co. Downgrades USANA Health Sciences to Underperform From Hold, Cuts Price Target to $53 From $78 MT
DA Davidson Adjusts USANA Health Sciences' Price Target to $76 from $86, Keeps Neutral Rating MT
DA Davidson Starts USANA Health Sciences at Neutral With $86 Price Target MT
ANALYST RECOMMENDATIONS : Delta Air Lines, Humana, JPMorgan, Shopify, W.W. Grainger... Our Logo
USANA HEALTH SCIENCES : Tigress Reiterates Buy Rating for USANA Health Sciences, Sets Price Target to $122 MT
USANA HEALTH SCIENCES : Roth Capital Adjusts Price Target on USANA Health Sciences to $126 From $107, Maintains Buy Rating MT
USANA HEALTH SCIENCES : Roth Capital Initiates Coverage on USANA Health Sciences With Buy Rating, $107 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
42.98 USD
Average target price
56.5 USD
Spread / Average Target
+31.46%
High Price Target
65 USD
Spread / Highest target
+51.23%
Low Price Target
48 USD
Spread / Lowest Target
+11.68%

Consensus detail

Consensus revision (last 18 months)

Analysts covering USANA Health Sciences, Inc.

DA Davidson
Jefferies & Co.
Tigress Financial
Roth Capital Partners

Ratings for USANA Health Sciences, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. USNA Stock
  4. Consensus USANA Health Sciences, Inc.